Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOPHYTIS-S-A-22837372/news/Biophytis-SA-Launches-OBA-Phase-2-Clinical-Study-in-Obesity-with-BIO101-20-Hydroxyecdysone-46394804/?utm_source=whatsapp&utm_medium=social&utm_campaign=share